CTRI Number |
CTRI/2018/03/012530 [Registered on: 13/03/2018] Trial Registered Prospectively |
Last Modified On: |
13/03/2018 |
Post Graduate Thesis |
Yes |
Type of Trial |
Interventional |
Type of Study
|
Drug Ayurveda Process of Care Changes |
Study Design |
Randomized, Parallel Group, Multiple Arm Trial |
Public Title of Study
|
Whether herbal eye drops help in management of dry eye syndrome ? |
Scientific Title of Study
|
"Role of Rajnidaaru eye drops and Rasayan Churna in the management of Shushkaakshipaka (Dry eye syndrome) - An open label double arm randomized clinical trial†|
Trial Acronym |
|
Secondary IDs if Any
|
Secondary ID |
Identifier |
NIL |
NIL |
|
Details of Principal Investigator or overall Trial Coordinator (multi-center study)
|
Name |
Dr Neeraj Dubey |
Designation |
P.G. Scholor |
Affiliation |
All india institue of ayurveda |
Address |
OPD No-101 1 st floor, Hospital Block ,All India Institute of Ayurveda Department of Shalakya Tantra,Gautampuri,Sarita Vihar,New Delhi South West DELHI 110076 India |
Phone |
|
Fax |
|
Email |
dubenrj@gmail.com |
|
Details of Contact Person Scientific Query
|
Name |
Dr Neeraj Dubey |
Designation |
P.G. Scholor |
Affiliation |
All india institue of ayurveda |
Address |
OPD No-101 1 st floor, Hospital Block ,All India Institute of Ayurveda Department of Shalakya Tantra,Gautampuri,Sarita Vihar,New Delhi South West DELHI 110065 India |
Phone |
8285520530 |
Fax |
|
Email |
dubenrj@gmail.com |
|
Details of Contact Person Public Query
|
Name |
Dr Neeraj Dubey |
Designation |
P.G. Scholor |
Affiliation |
All india institue of ayurveda |
Address |
OPD No-101 1 st floor, Hospital Block ,All India Institute of Ayurveda Department of Shalakya Tantra,Gautampuri,Sarita Vihar,New Delhi South West DELHI 110065 India |
Phone |
8285520530 |
Fax |
|
Email |
dubenrj@gmail.com |
|
Source of Monetary or Material Support
|
All India institute of Ayurveda,Gautampuri,Sarita Vihar,New Delhi-110076 |
|
Primary Sponsor
|
Name |
All india Institute of Ayurveda |
Address |
Department of Shalakya Tantra,Gautampuri,Sarita Vihar,New Delhi |
Type of Sponsor |
Research institution and hospital |
|
Details of Secondary Sponsor
|
|
Countries of Recruitment
|
India |
Sites of Study
|
No of Sites = 1 |
Name of Principal
Investigator |
Name of Site |
Site Address |
Phone/Fax/Email |
Dr Manjusha Rajagopala |
AIIA |
OPD No-101,Department of Shalakya Tantra,All India Institute of AyurvedaGautampuri,Sarita Vihar,New Delhi-110076 South West DELHI |
7600901848
bhatrajma2008@gmail.com |
|
Details of Ethics Committee
|
No of Ethics Committees= 1 |
Name of Committee |
Approval Status |
Institutional ethics committee |
Approved |
|
Regulatory Clearance Status from DCGI
|
|
Health Condition / Problems Studied
|
Health Type |
Condition |
Patients |
Patients with sign and symptoms of shuskakshipaaka (dry eye syndrome), |
|
Intervention / Comparator Agent
|
Type |
Name |
Details |
Intervention |
Rajnidaaru Eyedrop |
2 drops in both eyes will be administered twice a day for 42 days. |
Comparator Agent |
Rajnidaaru eyedrop with Rasayan Churna |
2 drops in both eyes will be administered twice a day for 42 days along with
3g Rasayan Churna twice a day for 42 day |
|
Inclusion Criteria
|
Age From |
18.00 Year(s) |
Age To |
60.00 Year(s) |
Gender |
Both |
Details |
1.Patients of either sex aged up to18 - 60 years.
2.Patients presenting with signs and symptoms of Dry eye syndrome.
3.Willing and able to participate in the study.
|
|
ExclusionCriteria |
Details |
1.Age group less than 18 and more than 60 years.
2.Severe cases of dry eye syndrome with complications like perforated corneal ulcer, Uveitis, Glaucoma.
3.Allergic eye disease i.e. vernal keratoconjunctivitis, Giant papillary conjunctivitis.
4.Non specific topical beta blocker users.
5.Inflammatory conditions like acute conjunctivitis.
6.Patients on steroids, oral contraceptive pills, estrogen replacement therapy or any other medication such as antispasmodic drugs like Atropine that may adversely affect the outcome of the study.
7.Patients suffering from major systemic illness necessitating long term drug treatment i.e. Psycho-epileptic drug users.
8.H/o hypersensitivity to the trial drug or any of its ingredients.
9.Persistent Contact Lens Users. |
|
Method of Generating Random Sequence
|
Not Applicable |
Method of Concealment
|
Alternation |
Blinding/Masking
|
Open Label |
Primary Outcome
|
Outcome |
TimePoints |
Reduction in clinical features of dry eye syndrome |
The patients will be assesed at the end of the study |
|
Secondary Outcome
|
Outcome |
TimePoints |
Changes in the quality of life |
The patients will be assesed at the end of the study |
|
Target Sample Size
|
Total Sample Size="30" Sample Size from India="30"
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" |
Phase of Trial
|
Phase 4 |
Date of First Enrollment (India)
|
15/04/2018 |
Date of Study Completion (India) |
Applicable only for Completed/Terminated trials |
Date of First Enrollment (Global) |
Date Missing |
Date of Study Completion (Global) |
Applicable only for Completed/Terminated trials |
Estimated Duration of Trial
|
Years="3" Months="2" Days="3" |
Recruitment Status of Trial (Global)
|
Not Yet Recruiting |
Recruitment Status of Trial (India) |
Not Yet Recruiting |
Publication Details
|
The outcomes of the study will be communicated to peer reviewed journals. |
Individual Participant Data (IPD) Sharing Statement
|
Will individual participant data (IPD) be shared publicly (including data dictionaries)?
|
Brief Summary
|
This study is an open label double arm randomised clinical trial comparing the efficacy of Rajnidaaru eye drops (2drop in each eye)along with Rasayan Churna(3g BD) and alone for 42 days in patients of shuskakshipaaka (Dry eye syndrome) for 30 days.The trail will be conducted in All India institute of Ayurveda.The primary outcome measures will be reduction in th clinical features of dry eye syndrome and the secondary outcomes will be changes in quality of life. |